establishment of screenig for congenital cytomegalovirus infection in newborns and analysis of clinical features of infected newborns

establishment of screenig for congenital cytomegalovirus infection in newborns and analysis of clinical features of infected newborns - screening of cytomegalovirus infection in newborns and analysis of clinical features of infected newborns

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002125

Enrollment

1200

Registered

2009-09-01

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

newborns

Interventions

measurement of CMV mRNA in the urine and blood of newborns

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: newborns who are positive for CMV mRNA in the urine and blood

Exclusion criteria

Exclusion criteria: newborns who are negative for CMV mRNA in the urine and blood

Design outcomes

Primary

Measure	Time frame
effecicacy of screenig system for CCMVI in newborns	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026